AquaBounty Technologies Q2 2026 Earnings Results & Report

AquaBounty Technologies EPS Results

• Actual EPS: -$0.26
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A
• EPS Beat Rate: 3 of last 8 quarters

AquaBounty Technologies Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

AquaBounty Technologies (NASDAQ:AQB) is a biotechnology and aquaculture company focused on developing land-based, land-based recirculating aquaculture systems (RAS) to produce Atlantic salmon. The company’s approach is designed to support year-round fish production while reducing reliance on ocean-based farming and limiting water use through treatment and reuse.

AquaBounty’s principal product is AquAdvantage salmon, a genetically engineered Atlantic salmon developed to reach market size more efficiently than conventional Atlantic salmon. The product received approval from the U.S. Food and Drug Administration for production, sale and consumption in the United States in 2020, following earlier regulatory approvals related to its production process. AquaBounty has also developed expertise in salmon breeding, hatchery operations and RAS technology.

The company has historically pursued production activities in North America and has operated or developed facilities in the United States and Canada, while its salmon production model has also involved international operations and partnerships. AquaBounty is headquartered in the United States and trades on the Nasdaq under the symbol AQB.